Dave Fornell, DAIC Editor

Dave Fornell, editor of DAIC Magazine

Blog | Dave Fornell, DAIC Editor | Coronavirus (COVID-19)| May 28, 2021

The Scramble for Knowledge During the COVID-19 Pandemic

A view from our video analytics panel this past month, showing India as the biggest source of traffic and showing three of the top performing videos. Brightcove analytics.

A view from our video analytics panel this past month, showing India as the biggest source of traffic and showing three of the top performing videos.

Sometimes it takes a major shift is the world to see things differently. As editor of DAIC, I often wonder if the content we produce actually helps cardiologists or other physicians with patient care. We pay close attention to analytics so we know what people have an interest in, but we are never sure if it is something they are actually applying to patient care. 

With the recent massive surge in COVID cases in India, we noticed a major spike in readers from that country concentrated on our COVID-19 content. In fact, traffic from India to our websites surpassed U.S. traffic starting in April, the first time ever that an audience from outside the U.S. became the majority driver of pageviews over U.S. readers. In the past month, our COVID-19 videos on DAIC and ITN had more than 18,000 pageviews. DAIC's most accessed top 10 articles articles in May included more than 30,000 pageviews just for COVID article content, with most of these being written last year during the first three U.S. COVID waves.  

In particular, the two biggest areas of Indian traffic was in radiology findings for COVID, and the use of  extracorporeal membrane oxygenation (ECMO) in supporting severely ill COVID patients when ventilators were not enough, or the patient requiring hemodynamic support due to organ failure.

I had a video interview last September with Ryan Barbaro, M.D., clinical assistant professor, pediatric critical care medicine, University of Michigan, and chair of the Extracorporeal Life Support Organization (ELSO) Registry Committee. He was an author of a study using the ELSO data on ECMO used to support critically ill COVID-19 patients. The study confirmed ECMO provides a survival benefit in appropriately selected patients. It was big news at the time because it validated what most large U.S. hospitals were already doing in attempts to save the sickest patients who were crashing hemodynamically and/or needed additional pulmonary support because their lungs were too damaged to get enough oxygen from ventilators.

As of January 2021, that video's traffic slowed to 1-3 views a day, but in late April this rapidly increased to more than 200 views a day. This spike in traffic was traced back to physicians in India looking for information on how to best treat severe COVID cases. Spikes were seen in a lot of our COVID coverage content, especially in videos on how U.S. centers are caring for these patients.

As of February 2021, there were more than 87,000 studies published on COVID-19 in the medical journals. The data from this vast number of studies varies from very good to very poor. Most of the data adds to the overall knowledge base on COVID, but few of these studies offer a definitive answer. A large number of these papers were single-center case studies or are too underpowered to show a clear clinical answer. 

With this "drinking from a fire hose" feeling many clinicians have regarding COVID information, I feel human nature takes hold and people do what they always do when they have a question and need a quick answer — they ask their peers and trusted colleagues. But for those short of experienced peers, some may turn to the next best thing, which is an experienced peer sharing data and their own experiences first hand in a video. 

As I sit here in my guest bedroom that was hastily converted into a home office more than a year ago, I often find myself asking what can I do to help make a difference in this fight. The answer is what I have been doing all along, produce COVID content that is practical for physicians and hospital departments to use in decision-making as they try to find the right answers as best they can. These analytics tell me we have done our small part and I hope it enabled someone on the other side of the planet to help their patients during an emergent situation. 

As an editor that covers new cutting-edge medical technology, I realized this week that it is sometimes the simple tech we overlook that might be able to make difference. In this case, a home internet connection and a laptop computer in a small guest bedroom. 

DAIC and its sister radiology magazine ITN have combined reached more than 2.6 million pageviews with just its COVID-19 content over the past year and half. 

Here are some of the pieces of content our comrades in arms in India are looking at:

VIDEO: ECMO Hemodynamic Support Effective in Sickest COVID-19 Patients — Interview with Ryan Barbaro, M.D.

ECMO Support Found Effective in Sickest of COVID-19 Patients

Kawasaki-like Inflammatory Disease Affects Children With COVID-19

VIDEO: Overview of Multisystem Inflammatory Syndrome in Children (MIS-C) in COVID-19 Exposed Children — Interview with Deepika Thacker, M.D.

VIDEO: How to Image COVID-19 and Radiological Presentations of the Virus

Addressing Atrial Fibrillation in the World of COVID-19

VIDEO: What Does COVID-19 Look Like in Lung CT Scans

Overview of Trials for Anticoagulation Therapy for COVID-19 Patients

COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events

The Long-term Cardiovascular Impact of COVID-19

The Cardiovascular Impact of COVID-19

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

VIDEO: COVID Vaccine Adenapathy Can Last Up to 10 Weeks — Interview with Yael Eshet, M.D.

VIDEO: COVID-19 Pneumonia Chest CT Scan Scroll Through

VIDEO: COVID Vaccine May Cause Enlarged Lymph Nodes on Mammograms — Interview with Constance "Connie" Lehman, M.D.

 

Related Content

#breakingnews The U.S. Food and Drug Administration (FDA) just granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. It is the first vaccine to be fully approved by the FDA, and experts say it is expected to open the door for further vaccine mandates.

Getty Images

News | Coronavirus (COVID-19) | August 23, 2021
August 23, 2021 — The U.S.
The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compromised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images #AHA #coronavirus #COVID19

The American Heart Association announced its support this week for the CDC and FDA recommendation that immuno-compormised patients should receive a third dose of the Pfizer or Moderna COVID vaccines. Getty Images

News | Coronavirus (COVID-19) | August 18, 2021 | By Dave Fornell, Editor
August 18, 2021 — The U.S.
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.

In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. 

Feature | Coronavirus (COVID-19) | July 30, 2021 | By Dave Fornell, Editor
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all
AHA president says COVID has a direct impact on the heart and preventive measures for heart disease largely went out the window during the pandemic

Getty Images

News | Coronavirus (COVID-19) | July 26, 2021
July 26, 2021 — Heart disease and stroke continue to kill more people in the U.S.
A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.

A new study with data from more than 10,000 COVID patients confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. Researchers believe statins, which attach to the ACE2 receptors, may block the virus from attaching to these same receptors. 

News | Coronavirus (COVID-19) | July 21, 2021
July 21, 2021 — In a new study from University of California San Diego School of Medicine, researchers have confirmed
New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. How to anticoagulate COVID patients. How to prevent thrombus in COVID patients.

New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. Getty Images
 

Feature | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — COVID-19 is m
Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months. From the study How a COVID-19 Infection Changes Blood Cells in the Long Run. Reasons for long COVID.

Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months.

News | Coronavirus (COVID-19) | July 15, 2021
July 15, 2021 — Using real-time deformability cytometry, researchers at the...
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.

News | Coronavirus (COVID-19) | June 28, 2021
June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in child
The U.S. Food and Drug Administration (FDA) announced June 25 it has added a warning on the Moderna and Pfizer COVID-19 messenger RNA (mRNA) vaccine fact sheets to explain they may cause myocarditis in rare cases as a side effect. The agency said the side effect is very rare and patients generally recover quickly, but it can disportionally affect younger patients in their teens and early 20s. Getty Images

Getty Images

News | Coronavirus (COVID-19) | June 28, 2021 | Dave Fornell, Editor
June 28, 2021 — The U.S.
A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP).

A small number of patients develop myocarditis after receiving the messenger RNA (mRNA) COVID-19 vaccines from Pfizer and Moderna. This recently raised concerns after numbers for this adverse reaction jumped in April and May, prompting review this week by the Centers for Disease Control and Prevention (CDC) Advisory Committee on the Immunization Practices (ACIP). Getty Images

Feature | Coronavirus (COVID-19) | June 24, 2021 | By Dave Fornell, Editor
A small number of patients develop inflammation leading to myocarditis after receiving the messenger RNA (mRNA)...